While ACTL6A amplification has been linked to increased SWI/SNF chromatin occupancy and YAP activation in HNSCC, the functional consequences of its expression and role as a therapeutic target are not defined. The gene discussed is ACTL6A; the disease is head and neck squamous cell carcinoma.